Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Dussupt

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|June 21, 2024
Human ESCRT-I and ALIX function as scaffolding helical filaments <i>in vivo</i>Stephanie J Spada, Kevin M Rose, Paola Sette, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
NPJ Vaccines|February 15, 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent miceIn-Jeong Kim, Michael P Tighe, Paula A Lanthier, et al.
Frontiers in Immunology|April 7, 2023
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamstersHannah A D King, Vincent Dussupt, Letzibeth Mendez-Rivera, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
NPJ Vaccines|February 17, 2024
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosetsIn-Jeong Kim, Olga Gonzalez, Michael P Tighe, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|June 21, 2024
Human ESCRT-I and ALIX function as scaffolding helical filaments <i>in vivo</i>Stephanie J Spada, Kevin M Rose, Paola Sette, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
NPJ Vaccines|February 15, 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent miceIn-Jeong Kim, Michael P Tighe, Paula A Lanthier, et al.
Frontiers in Immunology|April 7, 2023
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamstersHannah A D King, Vincent Dussupt, Letzibeth Mendez-Rivera, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
NPJ Vaccines|February 17, 2024
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosetsIn-Jeong Kim, Olga Gonzalez, Michael P Tighe, et al.
Pageof 6